JANESVILLE, Wis .-- (BUSINESS WIRE) - SHINE Medical Technologies LLC announced today that it has closed a Series C-5 financing of $ 150 million. Koch Disruptive Technologies (KDT) led the…
Flare Therapeutics is starting Series A funding of $ 82 million to advance its precision oncology pipeline based on BioSpace's novel approach to transcription factor drug discovery
To bring the next generation of nuclear reactor technology online this decade, Oak Ridge National Laboratory and Analysis and Measurement Services Corporation (AMS) have successfully completed loop…